The μ-opioid receptor antagonist D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr- NH2 (CTOP) [but not D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 (CTAP)] produces a nonopioid receptor-mediated increase in K+ conductance of rat locus ceruleus neurons

Molecular Pharmacology

Volumn 50, Issue 3, 1996, Pages 650-655

  Chieng, Billy ^a   Connor, Mark ^a   Christie, Macdonald J ^a  

^a University of Sydney   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DEXTRO PHENYLALANYLCYSTEINYLTYROSYL DEXTRO TRYPTOPHYLORNITHYLTHREONYLPENICILLAMINYLTHREONINAMIDE 2,7 DISULFIDE; OPIATE ANTAGONIST; SOMATOSTATIN DERIVATIVE; SOMATOSTATIN RECEPTOR;

ANIMAL TISSUE; ARTICLE; DRUG EFFECT; DRUG RECEPTOR BINDING; LOCUS CERULEUS; MALE; NONHUMAN; POTASSIUM CURRENT; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY;

ANIMALS; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; ENKEPHALIN, METHIONINE; ENKEPHALINS; KINETICS; LOCUS COERULEUS; MALE; NALOXONE; NARCOTICS; NEURONS; OPIOID PEPTIDES; PEPTIDES; POTASSIUM; POTASSIUM CHANNELS; QUINOXALINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, MU; SOMATOSTATIN;

EID: 0029814375     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. 3H]CTOP), a potent and highly selective peptide for μ opioid receptors in rat brain. J. Pharmacol. Exp. Ther. 248:73-80 (1989).
2. Kramer, T. H., J. E. Shook, W. Kazmierski, E. A. Ayres, W. S. Wire, V. J. Hruby, and T. F. Burks. Novel peptidic μ opioid antagonists: pharmacologic characterization in vitro and in vivo. J. Pharmacol. Exp. Ther. 249: 544-551 (1989).
3. Pelton, J. T., W. Kazmierski, K. Gulya, H. I. Yamamura, and V. J. Hruby. Design and synthesis of conformationally constrained somatostatin analogues with high potency and specificity for μ opioid receptors. J. Med. Chem. 29:2370-2375 (1986).
4. Kim, K. W., and B. M. Cox. Inhibition of norepinephrine release from rat cortex slices by opioids: differences among agonists in sensitivities to antagonists suggest receptor heterogeneity. J. Pharmacol. Exp. Ther. 267: 1153-1160 (1993).
5. Capogna, M., B. H. Gahwiler, and S. M. Thompson. Mechanism of μ-opioid receptor-mediated presynaptic inhibition in the rat hippocampus in vitro. J. Physiol. (Lond.) 470:539-558 (1993).
6. Sugita, S. R., and R. A. North. Opioid actions on neurons of rat lateral amygdala in vitro. Brain Res. 612:151-155 (1993).
7. Gulya, K., M. Krivan, N. Nyolczas, Z. Sarnyai, and G. L. Kovacs. Central effects of the potent and highly selective μ opioid antagonist D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2 (CTOP) in mice. Eur. J. Pharmacol. 150: 355-360 (1988).
8. Wang, Z., E. J. Bilsky, F. Porreca, and W. Sadee. Constitutive μ opioid receptor activation as a regulatory mechanism underlying narcotic tolerance and dependence. Life Sci. 54:PL339-PL350(1994).
9. Devine, D. P., P. Leone, and R. A. Wise. Mesolimbic dopamine neurotransmission is increased by administration of μ-opioid receptor antagonists. Eur. J. Pharmacol. 243:55-64 (1993).
10. - secretion by κ-opioid receptor agonism plus μ-opioid receptor antagonism. Eur. J. Pharmacol. 230:235-237 (1993).
11. Li, Y. J., and S. P. Duckles. Effect of opioid receptor antagonists on vasodilator nerve actions in the perfused rat mesentery. Eur. J. Pharmacol. 204:323-328 (1991).
12. Spanagel, R., A. Herz, and T. S. Shippenberg. Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway. Proc. Natl. Acad. Sci. USA 89:2046-2050 (1992).
13. Badiani, A., P. Leone, and J. Stewart. Intra-VTA injections of the mu-opioid antagonist CTOP enhance locomotor activity. Brain Res. 690:112-116 (1995).
14. Williams, J. T., and R. A. North. Opiate-receptor interactions on single locus coeruleus neurones. Mol. Pharmacol. 26:489-497 (1984).
15. North, R. A., and J. T. Williams. On the potassium conductance increased by opioids in rat locus coeruleus neurones. J. Physiol. (Lond.) 364:265-280 (1985).
16. Inoue, M., S. Nakajima, and Y. Nakajima. Somatostatin induces an inward rectification in rat locus coeruleus neurones through a pertussis toxin-sensitive mechanism. J. Physiol. (Lond.) 407:177-198 (1988).
17. Chieng, B., and M. J. Christie. Hyperpolarization by opioids acting on μ-receptors of a sub-population of rat periaqueductal gray neurones in vitro. Br. J. Pharmacol. 113:121-128 (1994).
18. North, R. A., J. T. Williams, A. Surprenant, and M. J. Christie. μ and δ receptors belong to a family of receptors that are coupled to potassium channels. Proc. Natl. Acad. Sci. USA 84:5487-5491 (1987).
19. Osborne, P. B., and J. T. Williams. Characterization of acute homologous desensitization of μ-opioid receptor-induced currents in locus coeruleus neurones. Br. J. Pharmacol. 115:925-932 (1995).
20. Miyake, M., M. J. Christie, and R. A. North. Single potassium channels opened by opioids in rat locus ceruleus neurons. Proc. Natl. Acad. Sci. USA 86:3419-3422 (1989).
21. Travagli, R. A., T. V. Dunwiddie, and J. T. Williams. Opioid inhibition in locus coeruleus. J. Neurophysiol. 74:519-528 (1995).
22. Perez, J., M. Rigo, K. Kaupmann, C. Bruns, K. Yasuda, G. I. Bell, H. Lubbert, and D. Hoyer. Localization of somatostatin (SRIF) SSTR-1, SSTR-2 and SSTR-3 receptor mRNA in rat brain by in situ hybridization. Naunyn-Schmiedeberg's Arch. Pharmacol. 349:145-160 (1994).
23. Raynor, K., W. A. Murphy, D. H. Coy, J. E. Taylor, J.-P Moreau, K. Yasuda, G. I. Bell, and T. Reisine. Cloned somatostatin receptors: identification of subtype-selective peptides and demonstration of high affinity binding of linear peptides. Mol. Pharmacol. 43:838-844 (1993).
24. Harris, G. C., and J. T. Williams. Transient homologous μ-opioid receptor desensitization in rat locus coeruleus neurons. J. Neurosci. 11:2574-2581 (1991).
25. Fiorillo, C. D., and J. T. Williams. Opioid desensitization: interactions with G-protein-coupled receptors in the locus coeruleus. J. Neurosci. 14:1479-1485 (1996).
26. Lachowicz, J. E., Y. Shen, F. J. Monsma, and D. R. Sibley. Molecular cloning of a novel G protein-coupled receptor related to the opiate receptor family. J. Neurochem. 64:34-40 (1995).
27. Meunier, J. C., C. Mollereau, L. Toll, C. Suaudeau, C. Moisand, P. Alvinerie, J. L. Butour, J. C. Guillemot, P. Ferrara, B. Monsarrat, H. Mazargul, G. Vassart, M. Parmentier, and J. Costentin. Isolation and structure of the endogenous agonist of opioid receptor-like ORL(1) receptor. Nature (Lond.) 377:532-535 (1995).
28. 1 receptor (opioid receptor-like 1) ligand, nociceptin, of inwardly rectifying K conductance in dorsal raphe nucleus neurones. Br. J. Pharmacol. 117:1609-1611 (1996).
29. Horan, P. J., K. D. Wild, W. M. Kazmierski, R. Ferguson, V. J. Hruby, S. J. Weber, T. P. Davis, L. Fang, R. J. Knapp, H. I. Yamamura, T. H. Kramer, T. F. Burks, W. D. Bowen, A. E. Takemori, and F. Porreca. Unexpected antinociceptive potency of cyclic [D-Tca1]CTAP: potential for a novel mechanism of action. Eur. J. Pharmacol. 233:53-62 (1993).